The factors that may influence the kinetics of sodium absorption from the normal and the diseased human small intestine are not well defined. The importance of two such factors, intestinal motility and parenteral administration of organomercurials, was separately investigated in the present study.
The significance of intestinal motility in man has recently been evaluated (3, 4) . In normal subjects, administration of methantheline bromide (Banthine) significantly reduced the rate of sodium absorption from the intestinal lumen (3) . The diminished transport of sodium was considered to be due to the concomitant reduction in intestinal motor activity. In patients with sprue in relapse, the rate at which sodium entered the circulating blood from the small bowel was also significantly reduced (4, 5) . The altered intestinal motor activity observed in this condition, as well as the presence of an enzymatic defect, was thought to play an important role in the abnormal sodium absorption (4) .
The effect of mercurials on sodium absorption has been studied in animals. A similarity between the transport mechanisms in the renal tubular and intestinal epithelial cells was suggested by the observation that, when mixed with the saline, and administered into the intestine, various mercurial compounds caused a decrease in the rate of intestinal absorption of the sodium (6) and chloride ions (6, 7) .
As a baseline for the present experiments, designed to evaluate the effect of motility and or-* A portion of this work has been published in abstract form (1) . ganomercurial administration on sodium absorption, studies were initially performed to determine the characteristics of normal sodium transport, including a measure of variations in normal rates of absorption. The term "absorption" as used in this paper refers to the unidirectional transfer of sodium from the intestinal lumen into the arterial blood.
METHODS
I. Sodium absorption Forty-five tests of radiosodium absorption were performed on 25 convalescent male hospital patients. All subjects were in normal electrolyte balance and were free of cardiac, hepatic, renal, endocrine and intestinal diseases. Their ages ranged from 25 to 70, with a mean of 43 years.
The observations were made in the morning after an overnight fast of at least 8 hours. The patient remained supine throughout the test. A Miller-Abbott tube was passed under fluoroscopic guidance and its tip positioned in the jejunum approximately 20 to 30 cm beyond the ligament of Treitz. The location of the tube was recorded roentgenographically at the beginning and end of each study. A Cournand needle was inserted into the brachial artery and secured in place. Control samples of blood were obtained. Sodium", 10 to 15 /Ac in 30 ml of isotonic saline warmed to 370 C, was introduced into the proximal jejunum at a constant rate during a 60 second period. Sodium', 7 to 12 Ac in 2 ml of isotonic saline, was injected intravenously over a 10 second period, the mid-point of the intravenous injection coinciding with the mid-point of the sodium" administration. During the second minute, the Miller-Abbott tube was flushed with 15 ml of nonradioactive, isotonic saline. The mid-point of the sodium' and sodium"2 injections was considered to be zero time, and 4 ml of arterial blood was withdrawn at 1-minute intervals for the first 12 minutes, at 3-minute intervals until 30 minutes had elapsed, and then at 5 to 10-minute intervals up to 1 hour.
To determine the degree of reproducibility of the absorption of sodium a second test was performed on 9 patients under identical conditions 1 hour after the control study. In The concentration of isotopic sodium was determined by counting 2 ml of plasma in a conventional well-type scintillation counter. Each sample of plasma containing both sodium's and sodium2' was counted for a period at least long enough to register 10,000 counts. One week later, the sodium2' (Tj = 15 hours) had decayed to negligible levels, and the plasma was again counted to determine the sodium's (T1 = 2.6 years) concentration. Sodium2' plasma levels on the day of the test were calculated by subtracting the sodium22 contribution. The dose of sodium' and sodium2' administered was determined by correcting for the total residual radioactivity in the syringes and in the Miller-Abbott tube. Absorption rates were calculated by the formula of Scholer and Code (8) using each patient's observed serial sodium2' plasma concentration values and sodium's spaces of distribution.
Conventional statistical methods were used to determine the 80 percentile range and linear correlation coefficients (R). The probability (p) that a correlation coefficient was obtained by chance was evaluated by analyses of variance and the t test (9) .
II. Intestinal motility
The motor activity of the small intestine was studied by detection and recording of intraluminal pressure in 21 studies. Two different systems were employed to record these pressure fluctuations. In 11 experiments a pressure-sensitive radio-telemetering capsule was used (10) . In X-ray studies. Preliminary to the radiosodium absorption experiments, radiographic studies were performed to gain information regarding: 1) the best location for placement of the Miller-Abbott tube, and 2) the rapidity of passage through the small bowel of a radiopaque solution administered at the same rate and in the same quantity as the sodium24 test solution and the subsequent flushing isotonic saline solution. Seventeen tests on 13 patients were performed. Thirty ml of sodium 3-acetylamino-2, 4, 6-triiodobenzoate (Urokon Sodium) was administered steadily into the small bowel through a MillerAbbott tube for 1 minute, followed by a wash of the same dye (15 ml) during the second minute. Radiographs of the abdomen were taken at 1 minute after the midpoint of the initial injection, and then at 2, 5, 10 and 20 minutes.
In the first 6 tests, the tip of the Miller-Abbott tube was placed in the transverse duodenum. In 2 studies a small quantity of dye was noted to reflux into the stomach. Thereafter, to avoid reflux, the tip of the Miller-Abbott tube was placed approximately 20 to 30 cm distal to the ligament of Treitz for the additional 8 X-ray studies and for all of the subsequent sodium experiments.
Examination of the radiographs revealed that at 1 minute the dye was distributed over an area of approximately 1 to 1.5 feet of the jejunum, and at 5 minutes
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was dispersed throughout the jejunum and most of the ileum. At 10 minutes some of the dye had entered the proximal colon in several patients. In 3 additional patients, in whom X-ray studies were performed following propantheline administration, the radiopaque dye remained localized in the upper jejunum for a period of at least 20 minutes. Radiopaque marker substances were not used in the sodium24 absorption experiments, in order to avoid possible alterations in osmolarity and viscosity of the test saline solution.
III. Mercaptonierin admninistration
Eleven additional convalescent hospital patients were used in this study. Two tests of sodium24 transport from intestinal lumen to arterial blood were performed on each patient. Since only intra-individual differences between arterial appearance curves of sodium24 were analyzed, sodium' was not used and spaces of distribution were not determined. Sodium24 was administered as in the first portion of the study and arterial blood serially sampled. In addition, a multi-holed urinary catheter was inserted into the bladder of each patient and timed urine collections were made. At the end of each collection period, 100 to 200 cc of air was injected to insure adequate collection. After the initial sodium24 absorption study and after at least two 15-minute urine collections, 2 ml of mercaptomerin was given intravenously to each of the 11 patients. A second intestinal absorption test was performed 70 to 120 minutes after the first test and timed to coincide with a marked diuresis, if diuresis occurred. a Urinary sodium and chloride were determined by standard methods (12, 13) .
Since no correction was made in these studies for variations in the "sodium space," experiments were carried out in 4 other patients to demonstrate that mercaptomerin did not appreciably alter the arterial disappearance curve of intravenously administered sodium. Sodium24 was given intravenously prior to mercaptomerin and an arterial disappearance curve plotted. The study was repeated after mercaptomerin and was timed to coincide with a urinary diuresis as in the absorption studies.
RESULTS
I. Characteristics of sodium absorption in normal patients Rate and total quantity of sodium24 absorbed following intrajejunal administration in 22 patients. At 5 minutes a mean total of 61.7 ± 15.3 per cent, and at 12 minutes a mean total of 94.0 ± 11.8 per cent of the administered dose were transferred from intestinal lumen to arterial blood (Fig- sodium21 were noted, approaching or reaching zero absorption. In seven patients absorption of more than 100 per cent of the administered dose occurred at 12 minutes.
The mean rate of absorption of sodium24 in terms of the quantity in the intestinal lumen was exponential between the second and tenth minute (Figure 2) . During this period, 21 per cent of the amount remaining in the intestine was absorbed per minute.
The initial period during which the plasma concentration curve rose sharply (Figure lb) corresponded to the period during which the absorption curve also rose rapidly and the largest quantity of sodium24 was absorbed (Figure la) Table II ). Correlation of absorption and motility before and after propantheline administration. Administration of propantheline in eight patients significantly reduced sodium24 plasma absorption and concentration values (Figures 4a and 4b) as compared with control levels (p < 0.05).
As an indication of a significant change from control levels, the initial slope of the post-anticholinergic plasma concentration curves ( Figure  4b ) afforded almost as much information as the calculated absorption data (Figure 4a ). The degree to which absorption was diminished in individual patients varied considerably and did not correlate well (R = + 0.28) with the control absorption values. (Figure 5 ). Nor was any correlation observed in these patients between the effect of propantheline on absorption and the severity of the anticholinergic effects such as tachycardia, xerostomia or blurred vision.
Intraluminal pressure was simultaneously recorded during the sodium absorption experiments in six of the eight patients before and after propantheline. Type I waves were abolished or markedly reduced following propantheline administration in four of the six patients. In the two remaining patients the total type I motor activity of the jejunum was significantly, although transiently, accentuated by the drug. Serial rhythmic, 11 minute, type I waves were noted for short periods before complete inhibition occurred. Effect of propantheline on type III activity could not be evaluated in three of the patients, since it was absent before the drug as well as after. Propantheline did abolish type III waves, however, in the studies on two patients in whom they were present in the control study.
There was a reduction of both absorption and motor activity following propantheline administration in four patients, but no obvious correlation was noted between the degree to which each of these functions was depressed. In the two pa- Effect of spreading sodium24 over jejunal mucosa on propantheline-induced inhibition of absorption. The lowing propantheline administration was not appreciably changed by mechanically spreading the sodium24 over approximately 2.5 to 3 feet of jejunal mucosal surface. In the six patients in whom the sodium24 was artificially dispersed ovter the jejunum, absorption at 5 and 12 minutes was 29 and 58 per cent of the administered dose, respectively, compared with absorption of 27 and 55 per cent in the eight patients who received propantheline, but in whom no attempt was made at dispersion of the test solution.
III. Effect of parenteral mercaptomerin administration on sodium absorption In seven of the 11 patients, a definite, marked increase in natriuresis followed mercaptomerin administration (Table III) . In three patients (J.J., R.A. and C.H.) the effect was present but not marked, and in one patient (R.M.) little effect was noted. The mean per cent increase in urinary flow for the 11 patients as compared with control rates of flow was 372 per cent per minute, SE + 98; the mean per cent increase of sodium excretion was 528, SE ± 137; the mean per cent increase of chloride excretion was 461, SE + 136.
The arterial plasma concentration curve of so- dium24 following mercaptomerin administration was in each case very similar to that of the control ( Figure 6 ). The mean differences between'the concentrations in the control test, minus those after mercaptomerin at 2, 3, 5 and 8 minutes, respectively, were: + 0.01, -0.15, -0.12, + 0.34. These values do not differ significantly from 0, 0; 0, 0 nor do they differ significantly from one another by Hotelling's t test or the conventional F test.
The difference in the control arterial appearance curves of sodium24 noted between different patients was very much greater than that noted between the control and post-mercaptomerin tests in the same patient.
The arterial disappearance curve of intravenous sodium24 in four other patients was unaffected by the administration of mercaptomerin (Figure 7) . DISCUSSION 
I. Sodium absorption
Sodium24 in an isotonic saline solution was transported rapidly from the intestinal lumen into the arterial circulation. In 22 control tests, the unidirectional transfer of 50 per cent of the test dose of isotopic sodium occurred in a mean of 4.3 minutes as compared with a mean of 6.1 minutes in 13 normal patients studied elsewhere (3, 4, 14) . Although it is possible that the absorption of greater than 100 per cent of administered sodium24 in seven patients represented re-excretion of sodium24 into the intestinal lumen, it is more likely that the errors of the method largely accounted-for this finding. Reproducibility of the rate at which sodium was absorbed from the intestine in nine repeat control tests was demonstrated to be quite good. On the basis of this reproducibility, the technique of using a patient as his own control was utilized in further studies. When only intraindividual differences were compared, as in the case of the evaluation of the effect of organomercurial administration on the absorption of sodium ions, sodium spaces of distribution were not required. This facilitated the study by eliminating the laborious mathematical calculations needed to integrate concentration with distribution values. It was first determined, however, that no change in the distribution of sodium resulted from mer-6. J. I% captomerin administration. When inter-individual differences in sodium absorption were analyzed, as in the study of intestinal motility and sodium absorption, it was essential to measure the rate of arterial appearance and disappearance of the test substance. The ability to accurately trace the distribution of sodium throughout the body (15) is essential to this technique, and offers a dimension in the study of absorption from the intact human small bowel which is lacking when rates of absorption of such commonly used substances as glucose, vitamin A, triolein and oleic acid are determined (16) . It should be noted, however, that the validity of this method (8, 17) depends in part upon how accurately the distribution of intravenous sodium22 reflects the distribution of the sodium24 absorbed from the intestine. Since sodium24 must pass through the intestinal mucosa, liver and/or lymphatics before reaching the systemic circulation, it is possible that the two isotopes are not identically distributed during the first few minutes. This question has not been completely resolved but experiments in dogs (18) in which sodium24 was injected into the portal vein suggest that the difference in route of administration may not introduce significant errors.
II. Intestinal motility and sodium absorption
Moderate positive correlation between type I waves, the "segmenting" waves, and transfer of sodium ions from intestinal lumen to arterial blood was observed. Particularly in patients in whom two control absorption and motility studies were performed, there was a parallel relationship between increased or decreased absorption and corresponding increase or decrease in segmental motor activity. However, the finding of normal rates of sodium transport in the presence of little intestinal motor activity of any type suggests that motility may not be as crucial a factor in the absorption of sodium from a saline medium as has been postulated (3, 4) . It is quite possible that intestinal motor activity may be of greater importance to the efflux of sodium from the lumen when the administered sodium is mixed with a more viscous substance such as food. A greater degree of churning would be then required to achieve continuous optimal mucosal contact. The observation that a constant proportion of sodium24 remaining in the intestinal lumen enters the blood stream every minute until 90 per cent is absorbed suggests that an optimal absorbing surface is achieved within a few minutes in the normal bowel. A similar exponential rate of absorption has been noted previously for D2O (18) .
Any discussion of the relationship between absorption and motility must include a consideration of the methods used to record motility. In these studies we have employed a device which detects the intraluminal pressure at one point in the jejununl1. The (20) . It is possible, therefore, that intestinal blood flow is altered by atropine or synthetic parasympathomimetic drugs. Although evidence is lacking, another possibility is that anticholinergics muay influence the metabolic activity of the intestinal mucosa which has been demonstrated to cause active sodium and chloride transport (21, 22) . The effect of propantheline on the hepatic clearance of sodium is an additional unknown consideration which may be significant.
III. Effect of mercaptomerin on sodium absorption
The present studies indicate that a parenteral organomercurial compound, mercaptomerin, does not appreciably affect the unidirectional transport of sodium24 ions during a period when a definite renal effect is manifest. This would suggest that the jejunal and ileal mucosa in man does not respond similarly to the renal tubules after a mercurial diuretic. This is in contrast to previous findings of decreased absorption of sodium (6, 7) and chloride (7) after mixing the saline with meralluride (Mercuhydrin). The difference in results between these experiments may be a function of the effective concentration of the mercurial at the mucosa. Blickenstaff (7) administered 2 ml of meralluride with the NaCl into a jejunal ring fistula in dogs. The resultant concentration of the mercurial compound at the mucosa was probably very greatly in excess of that achieved by parenteral administration of the same dose of mercaptomerin in man. Few data exist on the concentration of mercury in the intestine after parenteral organomercurial administration, and what information does exist is principally derived from animal studies. In the rat and dog, variable amounts of radioactivity were found in the gut wall after parenteral administration of Hg203-labeled chloromerodin [Neohydrin (23) ]. In these experiments, however, the intestine accounted for a very small fraction of the radioactivity found in the kidney. In one patient with advanced renal disease, autopsied 24 hours after administration of Hg203-labeled mercaptomerin, appreciable radioactivity was present in the colon (24) , but the small intestine was not studied.
The probable low concentration of a mercurial agent in the small intestinal mucosa of man would raise the question as to whether the failure to inhibit sodium24 absorption in these experiments is due, not to differences in the mechanism of sodium transport between intestine and renal tubules but, simply, to the concentration of the mercurial agent in the mucosa.
The possibility exists that a parenteral mercurial might affect intestinal mucosal transport of Na+ or Cl-ions at a time other than that chosen in these experiments. It seemed reasonable, however, to use the response of the kidney as an indication of mercurial action. SUMMARY 1. The quantitative characteristics of normal sodium absorption, i.e., unidirectional transfer of sodium ions from lumen to blood, have been studied by integrating the arterial appearance of sodium24 after jejunal administration with the arterial disappearance of sodium22 following intravenous administration. In 3. In nine patients, repeat control tests of intestinal absorption of sodium24 under identical conditions indicated a high degree of reproducibility. The technique of using a patient as his own control has been useful in the present studies on the effect of motility and organomercurial administration upon the transport of sodium from the intestinal lumen to arterial blood. 4 . Intestinal motility as reflected by jejunal intraluminal pressure was simultaneously recorded in 15 control tests of sodium24 absorption. There was some correlation between the amount absorbed and the amount of motor activity present. However, normal absorption occurred in several patients at a time when little motor activity was present. It is concluded that intestinal motility as here recorded probably does not play a critical role in the absorption of isotopic sodium from an isotonic saline solution in the normal small bowel.
5. The unidirectional transfer of sodium from intestinal lumen to arterial blood was significantly decreased after propantheline administration in eight patients. This reduction in absorption was not prevented in six additional patients who received propantheline and had artificial spread of the sodium24 over 3 feet of jejunal mucosal surface. These findings suggest that the inhibition of intestinal motility which occurs after an administration of an anticholinergic agent may not be primarily responsible for the decrease in absorption. 6 . The effect of an organomercurial, mercaptomerin, on the intestinal absorption of sodium24 has been studied in 11 convalescent patients. No effect on the unidirectional transport of sodium from the intestinal lumen to arterial blood was present at a time when a mercurial effect on the kidney was observed.
